The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Tetsuo Shoji

Department of Metabolism

Endocrinology and Molecular Medicine

Osaka City University

Graduate School of Medicine

Japan

[email]@med.osaka-cu.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University, Graduate School of Medicine, Japan. 2001 - 2012
  • Correspondence and offprint requests to: Tetsuo Shoji; E-mail:. 2012
  • Second Department of Internal Medicine, Osaka City University Medical School, 1-4-3, Asahi-machi, Japan. 2000 - 2004

References

  1. Thrice-weekly insulin injection with nurse's support for diabetic hemodialysis patients having difficulty with self injection. Shoji, T., Emoto, M., Mori, K., Morioka, T., Fukumoto, S., Takahashi, T., Matsumoto, A., Nishizawa, Y., Inaba, M. Osaka. City. Med. J (2012) [Pubmed]
  2. Decreased serum adrenal androgen dehydroepiandrosterone sulfate and mortality in hemodialysis patients. Kakiya, R., Shoji, T., Hayashi, T., Tatsumi-Shimomura, N., Tsujimoto, Y., Tabata, T., Shima, H., Mori, K., Fukumoto, S., Tahara, H., Koyama, H., Emoto, M., Ishimura, E., Nishizawa, Y., Inaba, M. Nephrol. Dial. Transplant. (2012) [Pubmed]
  3. Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients. Shoji, T., Masakane, I., Watanabe, Y., Iseki, K., Tsubakihara, Y. Clin. J. Am. Soc. Nephrol (2011) [Pubmed]
  4. Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia. Shoji, T., Hatsuda, S., Tsuchikura, S., Kimoto, E., Kakiya, R., Tahara, H., Koyama, H., Emoto, M., Tabata, T., Nishizawa, Y. Atherosclerosis (2009) [Pubmed]
  5. Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis. Shoji, T., Hatsuda, S., Tsuchikura, S., Shinohara, K., Kimoto, E., Koyama, H., Emoto, M., Nishizawa, Y. Atherosclerosis (2009) [Pubmed]
  6. Reverse epidemiology in hemodialysis patients. Lessons from Japanese registries. Shoji, T., Tsubakihara, Y., Nakai, S., Nishizawa, Y. Nephrol. Ther. (2008) [Pubmed]
  7. Body fat measurement in chronic kidney disease: implications in research and clinical practice. Shoji, T., Ishimura, E., Nishizawa, Y. Curr. Opin. Nephrol. Hypertens. (2007) [Pubmed]
  8. Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines. Shoji, T., Nishizawa, Y. Ther. Apher. Dial (2006) [Pubmed]
  9. Altered relationship between body fat and plasma adiponectin in end-stage renal disease. Shoji, T., Shinohara, K., Hatsuda, S., Kimoto, E., Fukumoto, S., Emoto, M., Tahara, H., Koyama, H., Ishimura, E., Miki, T., Tabata, T., Nishizawa, Y. Metab. Clin. Exp. (2005) [Pubmed]
  10. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Shoji, T., Shinohara, K., Kimoto, E., Emoto, M., Tahara, H., Koyama, H., Inaba, M., Fukumoto, S., Ishimura, E., Miki, T., Tabata, T., Nishizawa, Y. Nephrol. Dial. Transplant. (2004) [Pubmed]
  11. The association of antibodies against oxidized low-density lipoprotein with atherosclerosis in hemodialysis patients. Shoji, T., Kimoto, E., Shinohara, K., Emoto, M., Ishimura, E., Miki, T., Tsujimoto, Y., Tabata, T., Nishizawa, Y. Kidney Int. Suppl. (2003) [Pubmed]
  12. Advanced atherosclerosis in predialysis patients with chronic renal failure. Shoji, T., Emoto, M., Tabata, T., Kimoto, E., Shinohara, K., Maekawa, K., Kawagishi, T., Tahara, H., Ishimura, E., Nishizawa, Y. Kidney Int. (2002) [Pubmed]
  13. Atherogenic lipoprotein changes in diabetic nephropathy. Shoji, T., Emoto, M., Kawagishi, T., Kimoto, E., Yamada, A., Tabata, T., Ishimura, E., Inaba, M., Okuno, Y., Nishizawa, Y. Atherosclerosis (2001) [Pubmed]
  14. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. Shoji, T., Emoto, M., Shinohara, K., Kakiya, R., Tsujimoto, Y., Kishimoto, H., Ishimura, E., Tabata, T., Nishizawa, Y. J. Am. Soc. Nephrol. (2001) [Pubmed]
  15. Atherogenic lipoproteins in end-stage renal disease. Shoji, T., Ishimura, E., Inaba, M., Tabata, T., Nishizawa, Y. Am. J. Kidney Dis. (2001) [Pubmed]
  16. HOMA index to assess insulin resistance in renal failure patients. Shoji, T., Emoto, M., Nishizawa, Y. Nephron (2001) [Pubmed]
  17. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Shoji, T., Nishizawa, Y., Fukumoto, M., Shimamura, K., Kimura, J., Kanda, H., Emoto, M., Kawagishi, T., Morii, H. Atherosclerosis (2000) [Pubmed]
 
WikiGenes - Universities